RSS-Feed abonnieren
DOI: 10.4103/ijri.IJRI_73_19
Presidential address
Verantwortlicher Herausgeber dieser Rubrik:
- 1. IRIA Research and Education Foundation
- 2. Sono Summit
- 3. Technology
- 4. Collaborations
- 5. Youth Wing of Radiology
- References
Thank you, Dr. Mohanan for the heart warming introduction and thank you to the dignitaries on the dais and off the dais for your benevolent presence.
At the outset I would like to congratulate Team Chandigarh IRIA 2019 for organizing this successful and simply sublime conference for our radiology fraternity.
Now, I would like to extend my earnest gratitude to my team, my supporters, and above all the association for electing me and bestowing me with honor of becoming the President of this illustrious association. I thank all office bearers for their staunch support and past presidents for their guidance and blessings.
It truly is a privilege to become the President of the association of the most challenging and dynamic medical branches of our time, a branch which forms the crux of clinical diagnosis, a branch which is the frontrunner in technological facets, and a branch which constitutes the creamiest of folks and the most intellectual minds of not only medicine but also of the world. It is a genuinely humbling moment for me and I hope to live up to my promises, and more importantly to your expectations.
The members of this fraternity are my family and I want to make a dream home, that is, a dream association for all of us, where ideas, academia, and leadership will flourish and thrive, a place which will be a haven for radiologists and radiology.
With your support, during my presidential administration and tenure, I would like to accomplish feats for our association which shall take it to new heights. The main motives during my presidency will be unity, expansion, and dominance of our association. And to achieve the same, my agenda shall comprise the following things among others:
1. IRIA Research and Education Foundation
”Education is the most important weapon to bring about change”
-Dr. APJ Abdul Kalam
This initiative aims to improve radiology education, training, and oration, and to promote journals and research projects in radiology through the means of radiology seminars, funding grants and awards, enhancing radiology outreach programs, making academic passion universal in our field. This will, in turn, manifest as upliftment of medical services, patient care, and public health of India.
#
2. Sono Summit
This unprecedented meet, which will be organized in June of this year, will be a place for radiologists to share and inoculate their ideas and vision and learn “ultrasonography” discipline in more depth. This meet will also help address the PC & PNDT act issue on a new and broader magnitude. The PC & PNDT act, which was enforced in 1994 to curb female feticide and sex determination, has proved to be a bane for our radiological society. Not only that, it has negatively impacted innocent radiologists, rather than actually punishing the true culprits. It is a grave issue which has been addressed for many years. Now it is high time, we make tangible amends to the PC & PNDT act. We as IRIA will get through this challenge. But our efforts to empower the girl child will be stronger than ever by aggressively escalating the RAKSHA project which was launched last year. RAKSHA aims to provide goodwill to girls especially from the lower economic strata with earnest inputs on our behalf. At the same time, to reduce perinatal mortality in India, we are launching SAMRAKHAN Mission. SAMRAKSHAN will address Fetal Radiology and perinatal fetal health.
#
3. Technology
Technology is as imperative to radiology as radiologists themselves and we all know that; in the past 5 years there has been a draconian revolution of technology in our field. It is daunting and thrilling to see the introduction of these gizmos in our field. Together, we will explore this new era of AI and diagnosis with open mind and intellectual curiosity. A good news is we are launching AI forum which will keep close watch on this new kid on the campus. We will incorporate role of IRIA for development of AI in most structured fashion. We are sure we will stay ahead of time and grab appropriate opportunities.
We will also stay ahead on the digitization front. Most advanced website, IRIA app, and introduction of online forums are just a few examples.
#
4. Collaborations
“I can do things you cannot,
You can do things I cannot,
Together we can do great things.”
-Mother Teresa
Collaborations and alliance with international associations and radiological fraternities hold the key to broadening the horizons of Indian radiology. This year we are organizing India presents at Radiology Society of North America which is a grand feat in itself, and in addition to that we also have India meets European Congress lined up in 2021.
We will join hands with international radiology societies to deepen our knowledge and academia.
#
5. Youth Wing of Radiology
“Youth is a gift of nature but age is a work of art.”
While it is the responsibility of the invigorated young guns to take this association forward, it is even more of a duty for the seniors to guide them along the right path and show them the true light. And together take this association ahead. We are launching the Youth Wing of Radiology which will be exclusively working for the welfare of the postgraduate residents and young radiologists. I see marvellous feats in store for the association. For when radiology is united, it is unstoppable.
I would like to thank my “kafila, “that is, the Gujarat state chapter for their zealous and steadfast support in my journey, it truly means a lot; and above all my wonderful friends for being here and my family, which has been my backbone and my strength, my beautiful wife Nirali for her unconditional love and for always being my pillar in bad times and good times, and my loving children Shibiraj and Anokhi, I love you.
In Conclusion,
Let me share my dream with you, I have a dream, a dream to make IRIA among the top 5 radiology associations of the world. I urge every member of our association, from every state of this country, to join me in that cause.
I request all of you, all the members of IRIA, to feel free to contact me with any inputs for the betterment of our esteemed association.
I thank you. Lots of Love.
LONG LIVE IRIA!
#
#
Conflict of Interest
There are no conflicts of interest.
-
References
- 1 Taghizadeh Sarvestani R, Moradveisi B, Kompany F, Ghaderi E. Correlation between heart and liver iron levels measured by MRI T2* and serum ferritin in patients with β-thalassemia major. Int J Pediatr 2016; 4: 1559-67
- 2 Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci 2005; 1054: 18-24
- 3 Wood JC, Origa R, Agus A, Matta G, Coates TD, Galanello R. Onset of Cardiac iron loading in pediatric patients with thalassemia major. Haematologica 2008; 93: 917-20
- 4 Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C. et al. Survival and causes of death in thalassaemia major. Lancet 1989; 2: 27-30
- 5 Chouliaras G, Berdoukas V, Ladis V, Kattamis A, Chatziliami A, Fragodimitri C. et al. Impact of magnetic resonance imaging on cardiac mortality in thalassaemia major. J Magn Reson Imaging 2011; 34: 565-9
- 6 Hekmatnia A, Radmard AR, Rahmani AA, Adibi A, Khademi H. Magnetic resonance imaging signal reduction may precede volume loss in the pituitary gland of transfusion-dependent beta- thalassemic patients. Acta Radiol 2010; 51: 71-7
- 7 Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV. et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006; 8: 543-7
- 8 Aessopos A, Fragodimitri C, Karabatsos F, Hatziliami A, Yousef J, Giakoumis A. et al. Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia. Haematologica 2007; 92: 131-2
- 9 Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V. et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-62
- 10 Gandon Y. On-line liver iron quantification. Available from: https://imagemed.univ-rennes1.fr/en/mrquantif/online_quantif.php. [Last accessed on 2017 Mar 25]
- 11 Fahmy HS, Khater NH, El-Shahat HM, Madani AA, El Hadidy SS. Reassessing the value of MRI T2* in evaluation of hepatic and myocardial iron concentration: An institutional study. Egypt J Radiol Nucl Med 2015; 46: 1085-90
- 12 Voskaridou E. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassemia and sickle cell disease. Br J Haematol 2004; 126: 736-42
- 13 Fischer R, Longo F, Nielsen P, Engelhardt R, Hider RC, Piga A. Monitoring long term efficacy of iron chelation therapy by deferiprone and deferoxamine in patients with beta-thalassemia major application SQUID biomagnetic liver susceptometry. Br J Haematol 2003; 121: 938-48
- 14 Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008; 10: 42
- 15 Wood JC. Impact of iron assessment by MRI. Hematology Am Soc Hematol Educ Program 2011; 443-50
- 16 Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH. et al. Cardiovascular T2 star (T2*) magnetic resonance for early diagnosis of myocardial iron overload. Eur Heart J 22: 2171-9
- 17 Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B. et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial overload. J Magn Reson Imaging 2003; 18: 33-9
- 18 Buja LM, Roberts WC. Iron in the heart: Etiology and clinical significance. Am J Med 1971; 51: 209-21
- 19 Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J. et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009; 120: 1961-8
- 20 Pepe A, Meloni A, Rossi G, Cuccia L, D'Ascola GD, Santodirocco M. et al. Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy. J Cardiovasc Magn Reson 2013; 15: 1
- 21 Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S. et al. Correlative study of iron accumulation in liver, myocardium and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol 2006; 28: 311-5
- 22 Eghbali AMD. Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major B- thalassemia. Iranian J Pediatr Hematolo Oncol 2014; 4: 17-21
- 23 Mandal S, Sodhi KS, Bansal D, Sinha A, Bhatia A, Trehan A. et al. MRI for quantification of liver and cardiac iron in thalassemia major patients: Pilot study in Indian population. Indian J Pediatr 2017; 84: 276-82
- 24 Tziomalos K, Perifanis V. Liver iron content determination by magnetic resonance imaging. World J Gastroenterol 2010; 16: 1587-97
- 25 Noetzli LJ, Carson SM, Nord AS, Coates TD, Wood JC. Longitudinal analysis of heart and liver iron in thalassemia major. Blood 2008; 112: 2973-8
- 26 Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A. et al. Survival in medically treated patients with homozygous β-thalassemia. N Eng J Med 1994; 331: 574-8
- 27 Murphy CJ, Oudit GY. Iron-overload cardiomyopathy: Pathophysiology, diagnosis, and treatment. J Cardiac Failure 2010; 11: 888-900
- 28 Kayrak M, Acar K, Gul EE, Ozbek O, Abdulhalikov T, Sonmez O. et al. The association between myocardial iron load and ventricular repolarization parameters in asymptomatic beta-thalassemia patients. Adv Hematol 2012; 2012: 1705-10
- 29 Magri D, Sciomer S, Fedele F, Gualdi G, Casciani E, Pugliese P. et al. Increased QT variability in young asymptomatic patients with β-thalassemia major. Eur J Haematol 2007; 79: 322-9
- 30 Detterich J, Noetzli L, Dorey F, Bar-Cohen Y, Harmatz P, Coates T. et al. Electrocardiographic consequences of cardiac iron overload in thalassemia major. Am J Hematol 2012; 87: 139-44
- 31 Scheiber-Mojdehkar B, Zimmermann I, Dresow B, Goldenberg H. Differential response of non- transferrin bound iron uptake in rat liver cells on long-term and short-term treatment with iron. J Hepatol 1999; 31: 61-70
Publikationsverlauf
Artikel online veröffentlicht:
23. Juli 2021
© 2019. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
-
References
- 1 Taghizadeh Sarvestani R, Moradveisi B, Kompany F, Ghaderi E. Correlation between heart and liver iron levels measured by MRI T2* and serum ferritin in patients with β-thalassemia major. Int J Pediatr 2016; 4: 1559-67
- 2 Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci 2005; 1054: 18-24
- 3 Wood JC, Origa R, Agus A, Matta G, Coates TD, Galanello R. Onset of Cardiac iron loading in pediatric patients with thalassemia major. Haematologica 2008; 93: 917-20
- 4 Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C. et al. Survival and causes of death in thalassaemia major. Lancet 1989; 2: 27-30
- 5 Chouliaras G, Berdoukas V, Ladis V, Kattamis A, Chatziliami A, Fragodimitri C. et al. Impact of magnetic resonance imaging on cardiac mortality in thalassaemia major. J Magn Reson Imaging 2011; 34: 565-9
- 6 Hekmatnia A, Radmard AR, Rahmani AA, Adibi A, Khademi H. Magnetic resonance imaging signal reduction may precede volume loss in the pituitary gland of transfusion-dependent beta- thalassemic patients. Acta Radiol 2010; 51: 71-7
- 7 Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV. et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006; 8: 543-7
- 8 Aessopos A, Fragodimitri C, Karabatsos F, Hatziliami A, Yousef J, Giakoumis A. et al. Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia. Haematologica 2007; 92: 131-2
- 9 Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V. et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-62
- 10 Gandon Y. On-line liver iron quantification. Available from: https://imagemed.univ-rennes1.fr/en/mrquantif/online_quantif.php. [Last accessed on 2017 Mar 25]
- 11 Fahmy HS, Khater NH, El-Shahat HM, Madani AA, El Hadidy SS. Reassessing the value of MRI T2* in evaluation of hepatic and myocardial iron concentration: An institutional study. Egypt J Radiol Nucl Med 2015; 46: 1085-90
- 12 Voskaridou E. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassemia and sickle cell disease. Br J Haematol 2004; 126: 736-42
- 13 Fischer R, Longo F, Nielsen P, Engelhardt R, Hider RC, Piga A. Monitoring long term efficacy of iron chelation therapy by deferiprone and deferoxamine in patients with beta-thalassemia major application SQUID biomagnetic liver susceptometry. Br J Haematol 2003; 121: 938-48
- 14 Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008; 10: 42
- 15 Wood JC. Impact of iron assessment by MRI. Hematology Am Soc Hematol Educ Program 2011; 443-50
- 16 Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH. et al. Cardiovascular T2 star (T2*) magnetic resonance for early diagnosis of myocardial iron overload. Eur Heart J 22: 2171-9
- 17 Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B. et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial overload. J Magn Reson Imaging 2003; 18: 33-9
- 18 Buja LM, Roberts WC. Iron in the heart: Etiology and clinical significance. Am J Med 1971; 51: 209-21
- 19 Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J. et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009; 120: 1961-8
- 20 Pepe A, Meloni A, Rossi G, Cuccia L, D'Ascola GD, Santodirocco M. et al. Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy. J Cardiovasc Magn Reson 2013; 15: 1
- 21 Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S. et al. Correlative study of iron accumulation in liver, myocardium and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol 2006; 28: 311-5
- 22 Eghbali AMD. Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major B- thalassemia. Iranian J Pediatr Hematolo Oncol 2014; 4: 17-21
- 23 Mandal S, Sodhi KS, Bansal D, Sinha A, Bhatia A, Trehan A. et al. MRI for quantification of liver and cardiac iron in thalassemia major patients: Pilot study in Indian population. Indian J Pediatr 2017; 84: 276-82
- 24 Tziomalos K, Perifanis V. Liver iron content determination by magnetic resonance imaging. World J Gastroenterol 2010; 16: 1587-97
- 25 Noetzli LJ, Carson SM, Nord AS, Coates TD, Wood JC. Longitudinal analysis of heart and liver iron in thalassemia major. Blood 2008; 112: 2973-8
- 26 Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A. et al. Survival in medically treated patients with homozygous β-thalassemia. N Eng J Med 1994; 331: 574-8
- 27 Murphy CJ, Oudit GY. Iron-overload cardiomyopathy: Pathophysiology, diagnosis, and treatment. J Cardiac Failure 2010; 11: 888-900
- 28 Kayrak M, Acar K, Gul EE, Ozbek O, Abdulhalikov T, Sonmez O. et al. The association between myocardial iron load and ventricular repolarization parameters in asymptomatic beta-thalassemia patients. Adv Hematol 2012; 2012: 1705-10
- 29 Magri D, Sciomer S, Fedele F, Gualdi G, Casciani E, Pugliese P. et al. Increased QT variability in young asymptomatic patients with β-thalassemia major. Eur J Haematol 2007; 79: 322-9
- 30 Detterich J, Noetzli L, Dorey F, Bar-Cohen Y, Harmatz P, Coates T. et al. Electrocardiographic consequences of cardiac iron overload in thalassemia major. Am J Hematol 2012; 87: 139-44
- 31 Scheiber-Mojdehkar B, Zimmermann I, Dresow B, Goldenberg H. Differential response of non- transferrin bound iron uptake in rat liver cells on long-term and short-term treatment with iron. J Hepatol 1999; 31: 61-70